# FLUTICASONE PROPIONATE
> **ANDA219060** · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON · Approved 2025-08-15
## Drug
- **FDA Application Number:** ANDA219060
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** FLUTICASONE PROPIONATE
- **Generic name:** FLUTICASONE PROPIONATE NASAL
- **Active ingredients:** FLUTICASONE PROPIONATE
- **Dosage form:** SPRAY, METERED
- **Route:** NASAL
- **Marketing status:** Over-the-counter
- **Sponsor:** RUBICON
- **Manufacturer:** Advagen Pharma Ltd.
- **First approval:** 2025-08-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219060)
---
*MORVS · CC0 1.0*